Physician profile
Sanjay D Goel
NPI 1265538540
$100,629.33
in general payments reported to CMS, 2019-2025
23 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,870 · 2020: $9,208 · 2021: $14K · 2022: $8,075 · 2023: $28K · 2024: $22K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Long Term Medical Supply Or Device Loan: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,600 · Food and Beverage: $4,434 · Education: $4,405 · Travel and Lodging: $3,653 · Gift: $72.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,705.50 |
| Long Term Medical Supply Or Device Loan | $14,099.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,600.00 |
| Food and Beverage | $4,433.95 |
| Education | $4,405.18 |
| Travel and Lodging | $3,653.05 |
| Gift | $72.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $53,026.44 | 2019-2025 | Visumax, Veracity Surgical, Mel 90 |
| Carl Zeiss Meditec USA, INC. | $33,281.14 | 2021-2025 | Artevo 800, Visumax, Callisto Eye |
| Carl Zeiss Meditec Ag | $6,019.40 | 2020 | |
| Alcon Vision LLC | $2,904.17 | 2019-2025 | Wavelight Refractive Suite, Clareon, Wavelight Ex500 Excimer Laser |
| Bausch & Lomb Americas INC. | $2,401.27 | 2024-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Alcon Research LLC | $1,325.50 | 2023-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $364.54 | 2019-2021 | |
| Rxsight INC | $177.15 | 2021-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $171.01 | 2019-2025 | Tecnis Iol, Tecnis Simplicity |
| Sun Pharmaceutical Industries INC. | $144.66 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $130.81 | 2025 | Acthar |
| Allergan, INC. | $119.65 | 2022 | |
| Kala Pharmaceuticals, INC. | $89.97 | 2019-2021 | |
| Harrow Eye, LLC | $86.00 | 2024-2025 | Vevye, Iheezo |
| Novartis Pharmaceuticals Corporation | $65.90 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $62.00 | 2024 | Lensar Laser System |
| Abbvie INC. | $56.37 | 2022-2024 | |
| Oyster Point Pharma, INC. | $54.95 | 2022-2024 | Tyrvaya |
| Dompe US, INC. | $51.04 | 2020-2024 | Oxervate |
| Rayner Intraocular Lenses Limited | $49.41 | 2025 | Omidria |
| Omeros Corporation | $19.15 | 2021 | |
| Ocular Therapeutix, INC. | $16.25 | 2024 | Dextenza |
| Palette Life Sciences, INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.